Klin Farmakol Farm. 2020;34(3):130-134 | DOI: 10.36290/far.2020.023

Drugs induced dysnatremia: I. Drug hyponatremia

Milada Halačová1,2, Dalibor Černý1,3, Kateřina Sadilová1
1 Oddělení klinické farmacie Nemocnice Na Homolce
2 Ústav farmakologie 2. lékařské fakulty UK Praha
3 Farmakologický ústav 1. lékařské fakulty UK Praha

Hyponatremia is a relatively common and serious complication in outpatient and hospitalized patients. It is associated with increased mortality and morbidity. The clinical manifestation is very diverse and its development is due to a large number of causes, including iatrogenic drug-induced . The factors involved in the development of hyponatremia may be mutually combined, the causes are often not clearly identified and therefore drug hyponatremia remains undetected and underdiagnosed. The aim of this paper is to provide a literature review of the potential of individual drugs to induce hyponatremia, to describe the pathophysiological mechanism of this adverse effect and to facilitate its management in clinical practice.

Keywords: hyponatremia, osmolarity, drugs, diuretic agens, antidepressive agents, antipsychotics and antiepileptics.

Published: November 6, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Halačová M, Černý D, Sadilová K. Drugs induced dysnatremia: I. Drug hyponatremia. Klin Farmakol Farm. 2020;34(3):130-134. doi: 10.36290/far.2020.023.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Špaténková V, Škrábek P. Protokol diagnostiky a léčby hyponatremie a hypernatremie v neurointenzivní péči, Cesk Slov Neurol, 2015; 111(1): 34-37.
    2. Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia, Semin Nephrol, 2009; 29(3): 227-238. Go to original source... Go to PubMed...
    3. Upadlhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia, Am J Med, 2006; 119(7 A): 30-35. Go to original source... Go to PubMed...
    4. Hwang KS, Ho Kim G, Thiazide‑Induced Hyponatremia, Electrolyte Blood Press. 2010; 8(1): 51-57. Go to original source... Go to PubMed...
    5. Spital A. Diuretic‑induced hyponatremia. Am J Nephrol, 1999; 19: 447-452. Go to original source... Go to PubMed...
    6. Handler J. Well tolerated spironolactone related hyponatremia. J Clin Hyper, 2008; (10) 317-321. Go to original source... Go to PubMed...
    7. Van Assen S, Mudde AH. Severe hyponatremia in an amilorid/hydrochlorothiazid treated patient. Neth J Med 1999; 54: 108-113. Go to original source... Go to PubMed...
    8. Mori H, Kuroda Y, Imamura S, Toyoda A, Yoshida I, Kawakami M, Tabei K. Hyponatremia and/or hyperkalimia in patients treated with the standard dose of trimethoprim‑sulfamethoxazole. Intern Med, 42, 2003; 665-669. Go to original source... Go to PubMed...
    9. Babayev R, Terner S, Chandra S, Radhakrishnan J, Mohan S. Trimethoprim‑associated hyponatremia., Am J Kidney, DiS. 2013; 62(6): 1188-1192. Go to original source... Go to PubMed...
    10. Dreiher J, Porath A. Severe Hyponatremia Induced by Theophylline and Trimethoprim, Arch Intern Med., 2001; 161(2): 291-292. Go to original source... Go to PubMed...
    11. Liberopoulos E, Alexandridis G, Christidis D, Elisaf M. SIADH and hyponatremia with theophylline. Ann Pharmacother, 2002; 36: 1180-1182. Go to original source... Go to PubMed...
    12. Verghese C, de Leon J, Josiassen RC. Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophr Bull. 1996; 22: 455-464. Go to original source... Go to PubMed...
    13. Evenson RC, Jos CJ, Mallya AR. Prevalence of polydipsia among public psychiatric patients. Psychol Rep. 1987; 60: 803-807. Go to original source... Go to PubMed...
    14. Tan ECK, Lexomboon D, Sandborgh‑Englund G, Haasum Y, Johnell K. Medications That Cause Dry Mouth As an Adverse Effect in OlderPeople: A Systematic Review and Metaanalysis. J Am Geriatr Soc., 2018; 66(1): 76-84. Go to original source... Go to PubMed...
    15. SPC.
    16. Cersosimo MG, Raina GB, Calandra CR, Pellene A, Gutiérrez C, Micheli FE, Benarroch EE., Dry mouth: an overlooked autonomic symptom of Parkinson's disease., J Parkinsons, DiS. 2011; 1(2): 169-173. Go to original source... Go to PubMed...
    17. Movig KLL, Leufkens HGM, Lenderink AW, Egberts ACG. Serotoninergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur J Clin Pharmacol, 2002; 58: 143-148. Go to original source... Go to PubMed...
    18. Farmand S, Lindh J, Calissendorff J. Differences in associations of antidepressants and hospitalization due to hyponatremia, Am J Med, 2018; 131(1): 56-63. Go to original source... Go to PubMed...
    19. Gandhi S, Shariff SZ, Al.Jaishi A, Reiss, JP, Mamdani MM, Hackam DG, Li L, McArthur E, Weir MA, Garg AX. Second‑generation antidepressants and hyponatremia risk: a population‑based cohort study of older adults. Am J Kidney, DiS., 2017; 69: 87-96. Go to original source... Go to PubMed...
    20. Rose BD, Post TW. Clinical Physiology of Acid‑Base and Electrolyte Disorders, ed 5. New York, McGraw‑Hill, 2001; 702.
    21. Mogi T, Yoshono A, Ikemoto G, Nomura S. Mirtazapine as an alternative for selective serotonin reuptake inhibitor induced syndrome of inappropriate secretion of antidiuretik hormon. Pharmacopsychiatry, 2007; 40: 129-131.
    22. Cheah CY. Ladhams B, Fegan PG. Mirtazapine associated with profound hyponatremia:two case reports. Am J Geriatr Pharmacother., 2008; 6: 91-95. Go to original source... Go to PubMed...
    23. Lien YH. Antidepressants and hyponatremia, Am J Med, 2018; 131(1): 7-8. Go to original source... Go to PubMed...
    24. NazAli S, Bazzano LA. Hyponatremia in association with second‑generation antipsychotics: a systematic review of case reports, Ochsner Journal, 2018; 18: 230-235. Go to original source... Go to PubMed...
    25. Van Amelsvoort T, Bakshi R, Devaus CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbamazepine therapy: A review. Epilepsia 35; 181-188, 1994. Go to original source... Go to PubMed...
    26. Kuz GM, Manssourian A. Carbamazepine‑induced hyponatremia: Assesment of risk factor. Ann Pharmacother., 2005; 39: 1943-1946. Go to original source... Go to PubMed...
    27. Bressler RB, Huston DP. Water intoxication following moderate‑dose intravenous cyclophosphamide. Arch Intern Med 1985; 145: 548-549. Go to original source...
    28. Pham L, Shaer AJ, Marnejon T. Hyponatremia- a rare but serious complication of amiodarone: a case report and review of the literature, Case rep Nephrol urol, 2013; 3: 46-50. Go to original source... Go to PubMed...
    29. Brewster UC, Perazella MA: proton pump inhibitors and the kidney: Critical review. Clin Nephrol, 2007; 72: 65-72. Go to original source... Go to PubMed...
    30. Holden R, Jackson MA. Near‑fatal hyponatremic coma due to vasopressin over‑secretion after "extasy" (3,4,- methylenediosymethylamphetamine). Lancet, 1996; 347: 1052. Go to original source... Go to PubMed...
    31. Peters NA, Farrel LB, Smith JP. Hyperosmolar therapy for the treatment of cerebral edema, US Pharm, 2018; 43(1): 8-11.
    32. Fandino W. Understanding the physiological changes induced by mannitol: From the theory to the clinical practice in neuroanaesthesia, J Neuroanaesthesiol Crit Care, 2017; 4: 138-146. Go to original source...
    33. Nomani AZ1, Nabi Z, Rashid H, Janjua J, Nomani H, Majeed A, Chaudry SR, Mazhar AS. Osmotic nephorisis with mannitol: Review article. Ren Fail., 2014; 36: 1169-1176. Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.